Business Description
Alzamend Neuro Inc
NAICS : 541714
SIC : 2833
ISIN : US02262M4078
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 3.97 | |||||
Equity-to-Asset | -0.73 | |||||
Debt-to-Equity | -0.25 | |||||
Debt-to-EBITDA | -0.04 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -156.3 | |||||
3-Year EPS without NRI Growth Rate | -153.5 | |||||
3-Year FCF Growth Rate | -195.6 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 72.32 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
14-Day RSI | 8.72 | |||||
12-1 Month Momentum % | -29.78 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.49 | |||||
Quick Ratio | 0.49 | |||||
Cash Ratio | 0.41 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.7 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROA % | -552.04 | |||||
ROIC % | -2757.67 | |||||
3-Year ROIIC % | -8596.55 | |||||
ROC (Joel Greenblatt) % | -3562.32 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -0.92 | |||||
EV-to-Forward-EBIT | -1.58 | |||||
EV-to-EBITDA | -0.93 | |||||
EV-to-Forward-EBITDA | -0.33 | |||||
EV-to-FCF | -1.11 | |||||
Earnings Yield (Greenblatt) % | -108.7 | |||||
FCF Yield % | -88.86 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Alzamend Neuro Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -9.961 | ||
Beta | -0.19 | ||
Volatility % | 43.8 | ||
14-Day RSI | 8.72 | ||
14-Day ATR (€) | 0.000007 | ||
20-Day SMA (€) | 18.75 | ||
12-1 Month Momentum % | -29.78 | ||
52-Week Range (€) | 18.749999 - 32.849999 | ||
Shares Outstanding (Mil) | 3.89 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Alzamend Neuro Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Alzamend Neuro Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Alzamend Neuro Inc Frequently Asked Questions
What is Alzamend Neuro Inc(STU:9ZT)'s stock price today?
When is next earnings date of Alzamend Neuro Inc(STU:9ZT)?
Does Alzamend Neuro Inc(STU:9ZT) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |